Skotnicki M., Jadach B., Skotnicka A., Milanowski B., Tajber L., Pyda M., Kujawski J. Physicochemical characterization of co-amorphous atorvastatin-irbesartan system with a potential application in fixed-dose combination therapy. Pharmaceutics 13 (2021) 118. IF: 4.421
Froelich A., Osmałek T., Jadach B., Puri V., Michniak-Kohn B. Microemulsion-based media in nose-to-brain drug delivery. Pharmaceutics 13 (2021) 201. IF: 4.421
Wróblewska K.B., Plewa S., Długaszewska J., Froelich A., Muszalska-Kolos I. Design and evaluation of pharmaceutical availability, stability and quality of modified viscosity eye drops with choline salicylate. Eur. J. Pharm. Sci. 159 (2021) 105725. IF: 3.616
Jakubowska E.,Lulek J., The application of freeze-drying as a production method of drug nanocrystals and solid dispersions – A review, J. Drug Deliv. Sci. Technol. (2021): 62, art. 102357. IF: 2.734
Hejduk A., Czajka S., Lulek J., Impact of co-processed excipient particles solidity and circularity on critical quality attributes of orodispersible minitablets, Powder Technol. 387 (2021) 494-508. IF: 4.142
Czarczyńska-Goślińska B., Grześkowiak T., Frankowski R., Lulek J., Pieczak J., Zgoła-Grześkowiak A., Determination of bisphenols and parabens in breast milk and dietary risk assessment for Polish breastfed infants, J. Food Compost. Anal. 387 (2021) 1-10. IF: 3.721
Lijewski S., Tydlitat J., Czarczyńska-Goślińska B., Klikar M., Mielcarek J., Gośliński T., Sobotta Ł., Synthesis and physico-chemical properties of [(1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy]-thiophen-5-yl)-substituted tetrapyrazinoporphyrazine with magnesium(II) ion, Appl. Sci. (Basel) 11 (2021) 1-12. IF: 2.474
Cerbin-Koczorowska M., Waszyk-Nowaczyk M., Bakun P., Gośliński T., Koczorowski T., Current view on green tea catechins formulations, their interactions with selected drugs, and prospective applications for various health conditions., Appl. Sci. (Basel) 11 (2021) 4905. IF: 2.474